KLHL9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.128370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.133650E-01
Normal-vs-Stage2
9.057000E-03
Normal-vs-Stage3
6.736200E-03
Normal-vs-Stage4
3.099000E-01
Stage1-vs-Stage2
2.379600E-01
Stage1-vs-Stage3
7.406000E-02
Stage1-vs-Stage4
7.800400E-01
Stage2-vs-Stage3
3.820000E-01
Stage2-vs-Stage4
1.898370E-01
Stage3-vs-Stage4
1.141230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.183820E-02
Normal-vs-AfricanAmerican
2.214600E-01
Normal-vs-Asian
3.095500E-03
Caucasian-vs-AfricanAmerican
3.241200E-01
Caucasian-vs-Asian
3.750100E-02
AfricanAmerican-vs-Asian
5.849900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.829700E-02
Normal-vs-Female
7.836000E-03
Male-vs-Female
9.235200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.186970E-01
Normal-vs-Age(41-60Yrs)
1.627920E-02
Normal-vs-Age(61-80Yrs)
1.562150E-02
Normal-vs-Age(81-100Yrs)
5.404400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.437800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.636600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.035400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.329000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.045600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.272400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.445540E-02
Normal-vs-Daily Drinker
1.301420E-03
Normal-vs-Weekly Drinker
2.235600E-03
Normal-vs-Occasional Drinker
3.388400E-02
Normal-vs-Social Drinker
9.087900E-02
Non Drinker-vs-Daily Drinker
5.495600E-01
Non Drinker-vs-Weekly Drinker
7.093400E-01
Non Drinker-vs-Occasional Drinker
8.127800E-01
Non Drinker-vs-Social Drinker
5.099800E-02
Daily Drinker-vs-Weekly Drinker
2.810200E-01
Daily Drinker-vs-Occasional Drinker
4.363400E-01
Daily Drinker-vs-Social Drinker
7.024400E-03
Weekly Drinker-vs-Occasional Drinker
9.054800E-01
Weekly Drinker-vs-Social Drinker
7.937500E-02
Occasional Drinker-vs-Social Drinker
1.261380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.560760E-01
Normal-vs-Grade 2
1.326160E-01
Normal-vs-Grade 3
1.311820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.301400E-01
Grade 1-vs-Grade 3
8.704800E-01
Grade 1-vs-Grade 4
1.560760E-01
Grade 2-vs-Grade 3
7.269400E-01
Grade 2-vs-Grade 4
1.326160E-01
Grade 3-vs-Grade 4
1.311820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.209600E-02
Normal-vs-NonDiabetic
4.795800E-03
Diabetic-vs-NonDiabetic
4.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.359670E-03
Normal-vs-NoPancreatitis
1.235950E-02
Pancreatitis-vs-NoPancreatitis
1.429800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.261600E-02
Normal-vs-N1
5.935300E-03
N0-vs-N1
2.533800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.682400E-03
Normal-vs-TP53-NonMutant
6.904100E-02
TP53-Mutant-vs-TP53-NonMutant
1.703550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
